MAGNESIUM SULFATE IN THE TREATMENT OF PRE-ECLAMPSIA AND ITS ADVERSE EFFECTS (Atena Editora) (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorTSUGE, MARIANA HARUMI-
Autor(es): dc.contributor.authorTSUGE, HUGO YUKIO-
Data de aceite: dc.date.accessioned2023-04-17T12:35:56Z-
Data de disponibilização: dc.date.available2023-04-17T12:35:56Z-
Data de envio: dc.date.issued2023-03-30-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/725602-
Resumo: dc.description.abstractIntroduction: One of the most serious complications of pre-eclampsia is the occurrence of a seizure, called eclampsia. Magnesium sulfate is the first choice in the treatment of preeclampsia, despite the risk of toxicity and possible adverse effects. Objective: To analyze the evidence on the use of magnesium sulfate in preeclampsia and address its main adverse effects. Methodology: A bibliographic search was carried out in three databases from 2017 to 2022 using the descriptors: “pre-eclampsia”, “magnesium sulfate”, “preeclampsia”, “magnesium sulfate”. Outcome: Studies show that magnesium sulfate has proven to be a superior agent than other drugs in reducing the risk of eclampsia. The main regimens for using magnesium sulfate are Pritchard's and Zuspan's. Its use carries a small risk of magnesium intoxication. Side effects include: flushing, sweating, nausea, drowsiness, headache, blurred vision, loss of patellar reflex, respiratory paralysis and even cardiac arrest. Conclusion: Prophylaxis of eclamptic seizures with magnesium sulfate is a milestone in the clinical management of preeclampsia. When administered, careful monitoring for signs of intoxication is paramount.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectGestational hypertensionpt_BR
Título: dc.titleMAGNESIUM SULFATE IN THE TREATMENT OF PRE-ECLAMPSIA AND ITS ADVERSE EFFECTS (Atena Editora) (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais